"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row

  • 2:54
  • Published On: May 08, 2024
Cinema View
Embed
Amid widespread concern over Thrombosis with Thrombocytopenia Syndrome - a rare side-effect of the Covishield COVID-19 vaccine - the Serum Institute - which made the drug developed by British pharma giant AstraZeneca - has said that all its product packaging had "disclosed all rare to very rare side-effects", including TTS. The vaccine's safety "remains paramount", the company said Wednesday, pointing out the drug, as Covishield, had been "instrumental in saving millions of lives worldwide".

Related Videos

AstraZeneca Initiates A Global Withdrawal Of Its Covid-19 Vaccine
May 08, 2024 2:12
AstraZeneca Withdraws Covid Vaccine, Cites Commercial Reasons: Report
May 08, 2024 0:45
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
May 06, 2024 1:53
"Doctors Were Clueless, Didn't Suspect Vaccine": Man Whose Daughter Died Due To Vaccine Side-Effect
May 05, 2024 4:27
"All Drugs, Vaccines Come With Some Side-Effects": Top Expert
May 05, 2024 1:07
"No Vaccine Is 100% Effective Or 100% Safe": Expert On Covishield Concern
May 05, 2024 2:18
AstraZeneca Covid 19 Vaccine Side Effects | What Is TTS, A Rare Condition Caused By Covishield
May 01, 2024 4:03
Astrazeneca's Big U-Turn, Admits Rare Blood Clot Risk
April 30, 2024 2:21
AstraZeneca Makes Big U-Turn, Admits Covishield Can Cause Rare Side Effects
April 30, 2024 2:48
6.5% Covid Patients Tracked For A Year After Hospital Release Died: Study
August 22, 2023 1:33
Current Covid Strain Mild, 5-6 Million Covovax Doses Made: Adar Poonawalla
April 22, 2023 1:07
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination